Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : A.I.M Users Group Bulletin Board -- Ignore unavailable to you. Want to Upgrade?

To: Jim Battaglia who wrote (6594)	1/10/1999 8:51:00 AM
From: OldAIMGuy	Read Replies (1) \| Respond to of 18928

Thanks Jim, It looked too much like a "sector thing" to ignore. Luckily AIM has been happily taking profits recently. I've sold shares of CHIR and BMY most recently. BSX has had its own problems that were compounded by the Fall sell-off. It's recovered nicely from lows, but hasn't yet triggered any AIM sells. Of the three, it's the only one that's lean on Cash Reserve. Overall, this might begin a P/E contraction for the group. That might not be pretty. All the big funds own large amounts of Pharms. Best regards, Tom